Why the study?
Does MG53 promote sarcolemmal repair in the mdx mouse model of Duchenne muscular dystrophy?
Does MG53 promote sarcolemmal repair in the mdx mouse model of Duchenne muscular dystrophy?
Answers are grounded in this paper and cite their sources.
MG53 acts as a molecular bandage promoting sarcolemmal repair, identifying it as a potential new protein therapeutic for muscle disease.
MG53 promotes sarcolemmal repair in the mdx mouse model of Duchenne muscular dystrophy (Weisleder et al., this issue) and identifies a new protein therapeutic for muscle disease.
No takes yet. Share an insight, caveat, or question.
Burkin et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: